Ledger.Open graph →

SEC Form D · filed January 31, 2020

VistaGen Therapeutics, Inc

Offering

$2.8M

Sold

$2.8M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

South San Francisco, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

H. R. Snodgrass · South San Francisco, CAExec · Director Mark A. Mcpartland · South San Francisco, CAExec Jon S. Saxe · South San Francisco, CADirector Brian J. Underdown · South San Francisco, CADirector Mark A. Smith · South San Francisco, CAExec Jerry B. Gin · South San Francisco, CADirector Shawn K. Singh · South San Francisco, CAExec · Director Ann K. Cunningham · South San Francisco, CADirector Jerrold D. Dotson · South San Francisco, CAExec Joon H. Hwang · Seoul, M5Director Mark W. Brooker · Houston, TXDirector Yanghee Paik · Buena Park, CAExec Tyler Tringas · Miami, FLDirector Asia Capital Management, L.P · Grand Cayman, Cayman IslandsExec · Director R. D. Ravnaas · Forth Worth, TXDirector Earl Webb · Chicago, ILExec Barrett R. Sigmund · Seattle, WAExec Mark Rose · Chicago, ILExec · Director Ishaan Nerurkar · Berkeley, CADirector Michael Theilmann · Berkeley, CAExec · Director Colton Jang · Berkeley, CAExec Paul G. Roess · Chattanooga, TNExec · Director Mark W. Piper · SEATTLE, WAExec Scott Gazelle · Richmond, VADirector Steve Wallace · Richmond, VAExec Donna Edmonds · Richmond, VADirector Thomas P. Hoban, Jr · EVERETT, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗